Evidence for an apamin-sensitive, but not purinergic, component in the nonadrenergic noncholinergic relaxation of the rat gastric fundus.
The involvement of adenosine triphosphate (ATP) and carbon monoxide (CO) in the non-nitrergic nonpeptidergic component of high-frequency electrical field stimulation (EFS)-induced nonadrenergic noncholinergic (NANC) relaxation of longitudinal muscle strips from the rat gastric fundus was investigated. Under NANC conditions (1 microM atropine + 5 microM guanethidine), N(G)-nitro-L-arginine methyl ester (L-NAME, 1 mM) slightly reduced the amplitude, but did not affect the area under the curve (AUC) of EFS (13 Hz, 2 min)-induced relaxation of 9,11-dideoxy-9alpha,11alpha-methanoepoxy prostaglandin F(2alpha) (U46619, 0.1 microM)-precontracted strips. With L-NAME (1 mM) plus alpha-chymotrypsin (1 U ml(-1)), the amplitude and the AUC of relaxation were reduced to approximately two-third and one-third of controls, respectively. Pyridoxal-phosphate-6-azophenyl-2',4'-disulphonic acid (100 microM), apamin (0.3 microM), desensitization to ATP, suramin (100 microM), zinc protoporphyrin IX (300 microM) or ferrous haemoglobin (100 microM) did not inhibit the component of relaxation resistant to L-NAME plus alpha-chymotrypsin. L-NAME (1 mM) plus anti-vasoactive intestinal peptide (VIP) serum (1 : 100) reduced the amplitude and the AUC of relaxation to a similar extent as L-NAME (1 mM) plus alpha-chymotrypsin (1 U ml(-1)). Adding apamin (0.1 microM) to L-NAME (1 mM) plus anti-VIP serum (1 : 100) further reduced the amplitude and the AUC of relaxation. These findings suggest that the non-nitrergic nonpeptidergic component of NANC relaxation of the rat gastric fundus induced by high-frequency stimulation is mediated by a neurotransmitter that acts through apamin-sensitive mechanisms, that is neither ATP nor CO.
Currò
Diego
D
Institute of Pharmacology, School of Medicine, Catholic University of the Sacred Heart, L.go F. Vito, 1, I-00168 Rome, Italy. dcurro@rm.unicatt.it
De Marco
Teresina
T
Preziosi
Paolo
P
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D001030:Apamin / Q000494:pharmacology*; D002248:Carbon Monoxide / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005260:Female; D005748:Gastric Fundus / Q000187:drug effects* / Q000502:physiology*; D066298:In Vitro Techniques; D008297:Male; D009126:Muscle Relaxation / Q000187:drug effects* / Q000502:physiology*; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D011941:Receptors, Adrenergic / Q000502:physiology; D011950:Receptors, Cholinergic / Q000502:physiology; D011983:Receptors, Purinergic / Q000502:physiology
D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D011983:Receptors, Purinergic; D001030:Apamin; D002248:Carbon Monoxide; D000255:Adenosine Triphosphate; D019331:NG-Nitroarginine Methyl Ester